In a young adult with a chronic non‑healing anal fissure, should I obtain a quantitative fecal calprotectin test to assess for intestinal inflammation?

Should You Obtain Fecal Calprotectin in a Young Adult with Chronic Non-Healing Anal Fissure?

Yes, obtain a quantitative fecal calprotectin test in this patient to screen for underlying Crohn's disease, as a chronic non-healing anal fissure in a young adult warrants evaluation for inflammatory bowel disease before proceeding with standard fissure management.

Rationale for Testing

A chronic anal fissure that fails to heal with conservative management is atypical and raises concern for underlying Crohn's disease (CD), particularly in a young adult. Perianal manifestations, including fissures, can be the presenting feature of CD and may precede intestinal symptoms by months or years.

Key Evidence Supporting FC Testing

Fecal calprotectin effectively discriminates between Crohn's disease-related perianal disease and cryptoglandular pathology:

• FC ≥150 μg/g distinguishes CD-associated anal fistulas from cryptoglandular fistulas with high accuracy (AUC 0.900), even in patients without active luminal inflammation on endoscopy 1
• More recent data confirms FC ≥110 μg/g is significantly associated with CD in perianal fistulas (OR 12.5), with sensitivity 76% and specificity 80% 2
• Critically, elevated FC persists in CD patients even when they are medically treated or have no visible ulcers on colonoscopy 2, 1

Recommended Clinical Algorithm

Step 1: Obtain FC Test

• Use first bowel movement of the day for optimal sample 3
• Request quantitative measurement (not qualitative)

Step 2: Interpret Results

FC <50-100 μg/g:

• CD is unlikely
• Proceed with standard chronic fissure management (lateral internal sphincterotomy has >90% success rate 4)
• Consider other causes of non-healing (trauma, infection, malignancy if atypical features)

FC 100-150 μg/g:

• Borderline zone requiring clinical judgment
• Consider additional risk factors: family history of IBD, extraintestinal symptoms, weight loss, diarrhea
• If any concerning features present, proceed to colonoscopy

FC ≥150 μg/g:

• High probability of CD 1
• Mandatory ileocolonoscopy with biopsies before any surgical intervention
• Surgical sphincterotomy in undiagnosed CD can lead to catastrophic non-healing wounds and incontinence

Step 3: Management Based on Findings

If CD confirmed:

• Refer to gastroenterology for medical optimization before considering any surgical intervention
• Perianal CD requires systemic therapy (biologics), not local surgery as first-line

If colonoscopy negative despite elevated FC:

• Consider small bowel imaging (MR enterography)
• FC can remain elevated from perianal inflammation alone in CD
• Close follow-up warranted

Critical Pitfalls to Avoid

1. Never perform lateral internal sphincterotomy without excluding CD first - this can result in non-healing wounds requiring fecal diversion
2. Do not dismiss the possibility of CD based on absence of diarrhea or abdominal symptoms - perianal disease can be isolated
3. Do not rely on CRP alone - CRP is less sensitive than FC for intestinal inflammation and can be normal even with active CD 5
4. Recognize that "chronic" in a young adult is inherently suspicious - typical cryptoglandular fissures heal with conservative measures in 6-8 weeks

Why This Approach Prioritizes Morbidity and Quality of Life

Testing FC before surgical intervention prevents the devastating complication of performing sphincterotomy on undiagnosed CD, which can lead to:

• Non-healing surgical wounds
• Severe incontinence
• Need for fecal diversion
• Multiple revision surgeries
• Permanent disability

The test is non-invasive, relatively inexpensive, and can prevent life-altering complications while expediting appropriate treatment if CD is present.